Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 35 results.
User Information
Export Records
  1. 1.   Human monoclonal antibodies as candidate therapeutics against emerging viruses
  2. Jin, Yujia; Lei, Cheng; Hu, Dan; Dimitrov, Dimiter S; Ying, Tianlei
  3. Frontiers of medicine. 2017, Nov 20;
  1. 2.   Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
  2. Li, Wei; Zhu, Zhongyu; Chen, Weizao; Feng, Yang; Dimitrov, Dimiter S.
  3. Frontiers in Immunology. 2017, Nov 13; 8: 1554.
  1. 3.   Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets
  2. van Doremalen, Neeltje; Falzarano, Darryl; Ying, Tianlei; de Wit, Emmie; Bushmaker, Trenton; Feldmann, Friederike; Okumura, Atsushi; Wang, Yanping; Scott, Dana P; Hanley, Patrick W; Feldmann, Heinz; Dimitrov, Dimiter; Munster, Vincent J
  3. Antiviral Research. 2017, Jul; 143: 30-37.
  1. 4.   Analytical characterization of ch14.18 A mouse-human chimeric disialoganglioside-specific therapeutic antibody
  2. Soman, G.; Kallarakal, A. T.; Michiel, D.; Yang, X. Y.; Saptharishi, N.; Jiang, H. G.; Giardina, S.; Gilly, J.; Mitra, G.
  3. Mabs. 2012, Jan-Feb; 4(1): 84-100.
  1. 5.   Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody
  2. Prabakaran, P.; Gan, J. H.; Feng, Y.; Zhu, Z. Y.; Choudhry, V.; Xiao, X. D.; Ji, X. H.; Dimitrov, D. S.
  3. Journal of Biological Chemistry. 2006, JUN 9; 281(23): 15829-15836.
  1. 6.   Antibody-based inhibitors of HIV infection
  2. Choudhry, V.; Zhang, M. Y.; Dimitrova, D.; Prabakaran, P.; Dimitrov, A. S.; Fouts, T. R.; Dimitrov, D. S.
  3. Expert Opinion on Biological Therapy. 2006, MAY; 6(5): 523-531.
  1. 7.   Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor beta antibody (HuMik beta(1)), and correlation with functional activity using an antigen-transfected murine cell line
  2. Yang, X. Y.; Chen, E.; Jiang, H. G.; Hartmann, W. K.; Mitra, G.; Hecht, T.; Soman, G.
  3. Journal of Immunological Methods. 2006, APR 20; 311(1-2): 71-80.
  1. 8.   Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs
  2. Prabakaran, P.; Gan, J. H.; Wu, Y. Q.; Zhang, M. Y.; Dimitrov, D. S.; Ji, X. H.
  3. Journal of Molecular Biology. 2006, MAR 17; 357(1): 82-99.
  1. 9.   A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins
  2. Townsend, D. M.; Findlay, V. J.; Fazilev, F.; Ogle, M.; Fraser, J.; Saavedra, J. E.; Ji, X. H.; Keefer, L. K.; Tew, K. D.
  3. Molecular Pharmacology. 2006, FEB; 69(2): 501-508.
  1. 10.   Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies
  2. Zhu, Z. Y.; Dimitrov, A. S.; Bossart, K. N.; Crameri, G.; Bishop, K. A.; Choudhry, V.; Mungall, B. A.; Feng, Y. R.; Choudhary, A.; Zhang, M. Y.; Feng, Y.; Wang, L. F.; Xiao, X. D.; Eaton, B. T.; Broder, C. C.; Dimitrov, D. S.
  3. Journal of Virology. 2006, JAN; 80(2): 891-899.
  1. 11.   Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis
  2. Zudaire, E.; Martinez, A.; Garayoa, M.; Pio, R.; Kaur, G.; Woolhiser, M. R.; Metcalfe, D. D.; Hook, W. A.; Siraganian, R. P.; Guise, T. A.; Chirgwin, J. M.; Cuttitta, F.
  3. American Journal of Pathology. 2006, JAN; 168(1): 280-291.
  1. 12.   Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody
  2. Fuss, I. J.; Becker, C.; Yang, Z. Q.; Groden, C.; Hornung, R. L.; Heller, F.; Neurath, M. F.; Strober, W.; Mannon, P. J.
  3. Inflammatory Bowel Diseases. 2006, JAN; 12(1): 9-15.
  1. 13.   Novel human monoclonal antibodies to insulin-like growth factor (IGH)-II that potently inhibit the IGF receptor type I signal transduction function
  2. Feng, Y.; Zhu, Z. Y.; Xiao, X. D.; Choudhry, V.; Barrett, J. C.; Dimitrov, D. S.
  3. Molecular Cancer Therapeutics. 2006, JAN; 5(1): 114-120.
  1. 14.   Anthrax biosensor, protective antigen ion channel asymmetric blockade
  2. Halverson, K. M.; Panchal, R. G.; Nguyen, T. L.; Gussio, R.; Little, S. F.; Misakian, M.; Bavari, S.; Kasianowicz, J. J.
  3. Journal of Biological Chemistry. 2005, OCT 7; 280(40): 34056-34062.
  1. 15.   Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope
  2. Raviv, Y.; Viard, M.; Bess, J. W.; Chertova, E.; Blumenthal, R.
  3. Journal of Virology. 2005, OCT; 79(19): 12394-12400.
  1. 16.   Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus
  2. Yuste, E.; Johnson, W.; Pavlakis, G. N.; Desrosiers, R. C.
  3. Journal of Virology. 2005, OCT; 79(19): 12455-12463.
  1. 17.   Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A
  2. Witvrouw, M.; Fikkert, V.; Hantson, A.; Pannecouque, C.; O'Keefe, B. R.; McMahon, J.; Stamatatos, L.; De Clercq, E.; Bolmstedt, A.
  3. Journal of Virology. 2005, JUN; 79(12): 7777-7784.
  1. 18.   Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4
  2. Yang, Q. E.; Stephen, A. G.; Adelsberger, J. W.; Roberts, P. E.; Zhu, W. M.; Currens, M. J.; Feng, Y. X.; Crise, B. J.; Gorelick, R. J.; Rein, A. R.; Fisher, R. J.; Shoemaker, R. H.; Sei, S.
  3. Journal of Virology. 2005, MAY; 79(10): 6122-6133.
  1. 19.   Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS
  2. Zhang, M. Y.; Choudhry, V.; Xiao, X. D.; Dimitrov, D. S.
  3. Current Opinion in Molecular Therapeutics. 2005, APR; 7(2): 151-156.
  1. 20.   Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp
  2. Mori, T.; O'Keefe, B. R.; Sowder, R. C.; Bringans, S.; Gardella, R.; Berg, S.; Cochran, P.; Turpin, J. A.; Buckheit, R. W.; McMahon, J. B.; Boyd, M. R.
  3. Journal of Biological Chemistry. 2005, MAR 11; 280(10): 9345-9353.
  1. 21.   Targeting malignant B-cell lymphoma with a humanized anti-CD22 scFv-angiogenin immunoenzyme
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Rybak, S. M.
  3. British Journal of Haematology. 2005, MAR; 128(5): 602-609.
  1. 22.   The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo
  2. Embury, S. H.; Matsui, N. M.; Ramanujam, S.; Mayadas, T. N.; Noguchi, C.; Diwan, H. A.; Mohandas, N.; Cheung, A. T. W.
  3. Blood. 2004, NOV 15; 104(10): 3378-3385.
  1. 23.   Anti-interleukin-12 antibody for active Crohn's disease
  2. Mannon, P. J.; Fuss, I. J.; Mayer, L.; Elson, C. O.; Sandborn, W. J.; Present, D.; Dolin, B.; Goodman, N.; Groden, C.; Hornung, R. L.; Quezado, M.; Neurath, M. F.; Salfeld, J.; Veldman, G. M.; Schwertschlag, U.; Strober, W.
  3. New England Journal of Medicine. 2004, NOV 11; 351(20): 2069-2079.
  1. 24.   Identification of oxidized mitochondria proteins in alcohol-exposed human hepatoma cells and mouse liver
  2. Suh, S. K.; Hood, B. L.; Kim, B. J.; Conrads, T. P.; Veenstra, T. D.; Song, B. J.
  3. Proteomics. 2004, NOV; 4(11): 3401-3412.
  1. 25.   Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4
  2. Taub, D. D.; Mikovits, J. A.; Nilsson, G.; Schaffer, E. M.; Key, M. L.; Petrow-Sadowski, C.; Ruscetti, F. W.
  3. Cellular Immunology. 2004, AUG; 230(2): 65-80.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel